findmyKOL

Hani Kozman, MD

Basic profile

SUNY Upstate Medical University

ORCIDNone on fileNPI↗
✓ Full record
RegionSyracuse, NY · NortheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2023findmyKOL type: RegionalLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Hani Kozman is a Cardiology physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 37 publications with 571 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex.

571citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

90 Presidential Plz
5th Floor
Syracuse, NY 132022240

Telephone

315-464-9335

Registry record last updated 13 Jun 2016.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.8%
    Beta blocker19%
    Metoprolol Succinate47%Carvedilol22%Metoprolol Tartrate14%Atenolol5%Propranolol Hcl3%Nebivolol Hcl3%Bisoprolol Fumarate2%Propranolol Hcl Er2%Sotalol2%Labetalol Hcl1%
    Part D<11 patients
    Statin11.2%
    Atorvastatin Calcium79%Rosuvastatin Calcium12%Simvastatin6%Pravastatin Sodium3%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    13.7%
    Factor Xa inhibitor8.2%
    Eliquis72%Xarelto28%
    Part D≥58 patients
    P2Y12 inhibitor4.7%
    Clopidogrel94%Brilinta6%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    6.3%
    Potassium supplement2.7%
    Potassium Chloride100%
    Part D≥41 patients
    Proton pump inhibitor1.8%
    Omeprazole55%Pantoprazole Sodium46%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)47.1% facility · 52.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”